5YOO C H,NOH S H,SHIN D W,et al. Recurrences following curative resection for gastric carcinoma [J].Br J Surg,2000,87(2):236-242.
6DRICK R L,FLESSER M F. Pharmacokinetic problems in peritoneal drug administrati- on :tissue penet- ration and surface exposure[J]. Natl Cancer Inst,1997,89(7):480-487.
7NOH S H,YOO C H,CHUNG H C,et al. Early postoperative intraperi- toneal chemotherapy with mitomycinC,5-fluorouracil and cisplatin for advanced gastric cancer[J] . Oncology,2001,60(1):24-30.
8KIM J Y,BAE H S. A controlled clinical study of serosa 7 invasive gastric carcinoma patients who underwent surgery plus intraperitoneal hyperthermia chemo-perfusion(IHCP)[J]. Gastric Cancer,2001,4(1):27-33.
9SARNAIK A A, SUSSMAN J J, AHMAD S A, et al. Technology of intraperitoneal chemotherapy administration: a survey of techniques with a review of morbidity and mortality[J]. Surg Oncol Clin N Am, 2003,2(3):531-541.
3BECKER G. Medical and palliative management of malignant ascites [J].Cancer Treat Res,2007,134: 456-467.
4SHILBATA M, NEZU T, FUJISAKI S, et al. Clinical potential of biological response modifiers combined with chemotherapy for gastric cancer. Japanese experience [J]. Dig Surg,2002,19(4):255 -260.
